Untitled Document
Recall how hydrogen peroxide is poured on wounds to kill germs. Well
now researchers clearly show high-dose vitamin C, when administered intravenously,
can increase hydrogen peroxide (H2O2) levels within cancer cells and kills them.
I.V. vitamin C was also demonstrated to kill germs and may be an effective therapy
for infectious disease.
With a growing body of evidence mounting, National Institutes of Health
(NIH) researchers conceded today that intravenous vitamin C may be an effective
treatment for cancer. Last year the same researchers reported a similar study
but the news media failed to publish it.
The latest study, published in the Proceedings of the National Academy of Sciences,
confirms the work of Nobel-Prize winner Dr. Linus Pauling who conducted cancer
research in the 1970s with vitamin C. Dr. Pauling's studies were discredited
at the time by poorly conducted research studies at the Mayo Clinic.
Unlike cancer drugs, I.V. vitamin C selectively killed cancer cells, but not
healthy cells, and showed no toxicity. The ability of intravenous vitamin C
to kill lymphoma cells was remarkable – almost 100% at easily achievable
blood serum concentrations.
For inexplicable reasons, NIH researchers continue to maintain high-dose oral
vitamin C can produce a limited increase in serum vitamin C concentrations.
However, their earlier study published in 2004 clearly showed oral-dose vitamin
C can achieve three times greater blood concentration than previously thought
possible, a fact which negates the current Recommended Dietary Allowance for
vitamin C. [Annals Internal Medicine 140:533–7, 2004] NIH researchers
refuse to issue a retraction of their earlier flawed research which mistakenly
claimed humans cannot benefit from high-dose oral vitamin C supplements.
The NIH also offered no explanation why it has taken 35 years to confirm
the work of Dr. Linus Pauling.
